Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does THALIDOMIDE Cause Intentional product use issue? 243 Reports in FDA Database

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

According to the FDA Adverse Event Reporting System (FAERS), 243 reports of Intentional product use issue have been filed in association with THALIDOMIDE (Thalomid). This represents 1.4% of all adverse event reports for THALIDOMIDE.

243
Reports of Intentional product use issue with THALIDOMIDE
1.4%
of all THALIDOMIDE reports
26
Deaths
30
Hospitalizations

How Dangerous Is Intentional product use issue From THALIDOMIDE?

Of the 243 reports, 26 (10.7%) resulted in death, 30 (12.3%) required hospitalization, and 9 (3.7%) were considered life-threatening.

Is Intentional product use issue Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for THALIDOMIDE. However, 243 reports have been filed with the FAERS database.

What Other Side Effects Does THALIDOMIDE Cause?

Plasma cell myeloma (1,652) Off label use (1,356) Death (1,161) Neuropathy peripheral (1,068) Drug ineffective (789) Pneumonia (694) Fatigue (643) Constipation (461) Thrombocytopenia (429) Neutropenia (420)

What Other Drugs Cause Intentional product use issue?

INFLIXIMAB (11,028) RITUXIMAB (9,602) INFLIXIMAB-DYYB (7,549) TOCILIZUMAB (5,078) METHOTREXATE (4,087) PREDNISONE (3,961) ABATACEPT (3,693) ADALIMUMAB (3,557) NIVOLUMAB (3,297) LEFLUNOMIDE (3,280)

Which THALIDOMIDE Alternatives Have Lower Intentional product use issue Risk?

THALIDOMIDE vs THALOMID THALIDOMIDE vs THEOPHYLLINE THALIDOMIDE vs THEOPHYLLINE ANHYDROUS THALIDOMIDE vs THIAMINE THALIDOMIDE vs THIOCOLCHICOSIDE

Related Pages

THALIDOMIDE Full Profile All Intentional product use issue Reports All Drugs Causing Intentional product use issue THALIDOMIDE Demographics